CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention

Clinical trial NCT06283888 · RECRUITING

Trial details

NCT number: NCT06283888
Sponsor: Zunyi Medical College
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

ACS - Acute Coronary Syndrome CYP2C19 Polymorphism

Start date: 2024-04-01
Primary completion: 2028-04-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.